found that SHP2 inhibition could relieve systemic lupus erythematosus by reducing the number of double‐negative T cells, regulating ERK/MAPK signal, and reducing IFN‐γ production.35 This evidence concerns the gene MAPK1 and systemic lupus erythematosus.